Impact of a clinical decision support system on paediatric drug dose prescribing: a randomised within-subject

Lukas Higi1,2, Raffael Schmitt3, Karin Käser2

  • 1Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland lukas.higi@unibas.ch.

BMJ Paediatrics Open
|January 25, 2023
PubMed

Insights

A clinical decision support system (CDSS) significantly reduces pediatric drug dosing errors and speeds up prescribing. The PEDeDose system proved safer and more efficient than manual calculations using product information.

Area of Science:

  • Pediatric pharmacology
  • Clinical informatics
  • Patient safety

Background:

  • Drug dosing errors are a major cause of preventable harm in children.
  • Human factors contribute significantly to these errors due to complex pediatric pharmacotherapy and demanding healthcare environments.
  • Clinical decision support systems (CDSS) offer a promising strategy to prevent prescribing errors.

Purpose of the Study:

  • To compare the accuracy and efficiency of a CDSS (PEDeDose) against traditional methods for pediatric drug dose calculation.
  • To evaluate the impact of a CDSS's built-in calculator versus manual calculation using product information.

Main Methods:

  • A randomized within-subject trial involving 52 healthcare professionals (HCPs) simulating dose derivation for 18 hypothetical pediatric cases.
  • Comparison of the CDSS PEDeDose (with built-in calculator) against the Summary of Product Characteristics (SmPC) with a pocket calculator.
  • Assessment of dose calculation errors and time required for each method.

Main Results:

  • The odds of an erroneous dosage were 12 times higher when using the SmPC with a pocket calculator compared to the CDSS (OR 0.08, 95% CI 0.02 to 0.36, p<0.001).
  • Dosage derivation using the CDSS resulted in a 45% reduction in time (95% CI 39% to 51%, p<0.001).
  • Using the CDSS without its built-in calculator did not significantly reduce errors, highlighting the importance of the integrated tool.

Conclusions:

  • The CDSS PEDeDose demonstrates superior safety and efficiency compared to manual dose calculation in pediatrics.
  • Relying solely on a dosing database without an integrated calculator is insufficient for substantial error reduction.
  • The CDSS PEDeDose is expected to enhance safety and expedite the prescribing process in clinical practice.
Abstract

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.7K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
156
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.6K
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
121